Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) announced that its board of directors has approved the granting of stock options exercisable for a total of 2,725,000 common shares to its directors, officers and consultants at an exercise price of CA$0.15 per common share. According to the update, all options were granted pursuant to the company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange. The options are subject to a vesting period of one year, with 1/4 of the options vesting three months after the date of the grant and the remaining vesting on a quarterly basis thereafter. Subject to the optionees continuing to act as directors, officers or consultants of the company, the options expire five years from the date of the grant.
To view the full press release, visit https://ibn.fm/trssF
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM) (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
